Impact News +++ Ad-hoc News: Aumann AG (EQS) +++ AUMANN Aktie +9,57%

COOPER COMPANIES Aktie

>COOPER COS Aktienkurs

55.25 EUR +3.4% (TradegateBSX)

Ask: 55.84 EUR / 99 Stück

Bid: 53.8 EUR / 103 Stück

Tagesumsatz: 289 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

COOPER COS Aktie über LYNX handeln

Intraday

1 Jahr

>COOPER COS Performance

1 Woche: +1,5%

1 Monat: +1,0%

3 Monate: -24,2%

6 Monate: -18,4%

1 Jahr: -10,2%

laufendes Jahr: -23,6%

>COOPER COMPANIES Aktie

Name:

COOPER COMPANIES

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US2166485019 / A402VX

Symbol/ Ticker:

CP60 (Frankfurt) / COO (NASDAQ)

Kürzel:

FRA:CP60, ETR:CP60, CP60:GR, NASDAQ:COO

Index:

Webseite:

https://www.coopercos.com..

Profil:

The Cooper Companies, Inc. is a global medical device company focused on eyecare and women’s health, headquartered in San Ramon, California. The business operates through two main segments: CooperVision and CooperSurgical. CooperVision develops, ma..
>Volltext..

Marktkapitalisierung:

10115.3 Mio. EUR

Unternehmenswert:

12114.89 Mio. EUR

Umsatz:

3567.23 Mio. EUR

EBITDA:

941.32 Mio. EUR

Nettogewinn:

344.87 Mio. EUR

Gewinn je Aktie:

1.74 EUR

Schulden:

2147.69 Mio. EUR

Liquide Mittel:

107.4 Mio. EUR

Operativer Cashflow:

Bargeldquote:

0.08

Umsatzwachstum:

-7.61%

Gewinnwachstum:

-15.53%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Div. Historie:

26.07.23 - 0.00160875€
20.01.23 - 0.00160875€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

COOPER COMPANIES, COOPERCOMPANIES, COOPER COS

Letzte Datenerhebung:

05.06.26

>COOPER COS Kennzahlen

Aktien/ Unternehmen:

Aktien: 195.11 Mio. St.

Frei handelbar: 99.34%

Leerverk. Aktien: 2.62%

Rückkaufquote: 3.1%

Mitarbeiter: 15000

Umsatz/Mitarb.: 0.23 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 40.71%

Bewertung:

KGV: 31.18

KGV lG: 13.36

KUV: 2.88

KBV: 1.47

PEG-Ratio: -

EV/EBITDA: 12.87

Rentabilität:

Bruttomarge: 60.69%

Gewinnmarge: 9.67%

Operative Marge: 17.19%

Managementeffizenz:

Gesamtkaprendite: 3.26%

Eigenkaprendite: 4.87%

>COOPER COS Peer Group

Gesundheit, Augenmedizin/ Sehhilfen, Medizinprodukte & -technik/ Implantate/ Wundpflege

>COOPER COS Chart & Kurs - NASDAQ

>COOPER COS News

05.06.26 - 06:27	Cooper Companies forecasts $4.28B-$4.32B fiscal 2026 revenue while advancing CooperSurgical review (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.06.26 - 01:45	Here′s What Key Metrics Tell Us About The Cooper Companies (COO) Q2 Earnings (Zacks)
	Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

05.06.26 - 01:00	The Cooper Companies (COO) Beats Q2 Earnings and Revenue Estimates (Zacks)
	The Cooper Companies (COO) delivered earnings and revenue surprises of +9.67% and +2.57%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?...

05.06.26 - 00:48	Full Transcript: Cooper Companies Q2 2026 Earnings Call (Benzinga)
	Importance Rank: 1 read more...

05.06.26 - 00:30	Cooper Companies übertrifft Q2-Prognosen 2026, Aktie legt zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

04.06.26 - 23:42	Cooper Companies Posts Q2 Loss Hurt By One-Time Litigation Charge, Revenue Rises 8% (AFX)
	WASHINGTON (dpa-AFX) - Cooper Companies, Inc. (COO) on Thursday posted a net loss due to a substantial litigation-related charge tied to a 2023 product recall. However, the company reported higher......

04.06.26 - 22:27	The Cooper Companies Non-GAAP EPS of $1.21 beats by $0.12, revenue of $1.08B beats by $30M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.06.26 - 22:18	CooperCompanies Announces Second Quarter 2026 Results (GlobeNewswire EN)
	SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026....

03.06.26 - 23:39	The Cooper Companies Q2 2026 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.06.26 - 20:30	The Cooper Companies Gears Up to Post Q2 Earnings: What′s in Store? (Zacks)
	CooperVision momentum and MyDay/MiSight adoption are likely to fuel COO's Q2, but Japan softness and fertility uncertainty remain key watch points....

01.06.26 - 16:45	Seeking Clues to The Cooper Companies (COO) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
	Beyond analysts' top-and-bottom-line estimates for The Cooper Companies (COO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2026....

04.05.26 - 22:18	CooperCompanies Appoints Paul Keel to its Board of Directors (GlobeNewswire EN)
	SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board....

30.04.26 - 22:18	CooperCompanies Announces Release Date for Second Quarter 2026 (GlobeNewswire EN)
	SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments....

30.04.26 - 14:31	Druck durch Aktivisten: Wolfe Research sieht bei Cooper Companies eine Investmentchance (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.04.26 - 13:48	Cooper Companies Earnings Preview: What to Expect (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

24.03.26 - 19:30	3 Reasons Why Growth Investors Shouldn′t Overlook The Cooper Companies (COO) (Zacks)
	The Cooper Companies (COO) is well positioned to outperform the market, as it exhibits above-average growth in financials....

23.03.26 - 16:30	The Cooper Companies (COO) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

17.03.26 - 13:54	Is Cooper Companies Stock Underperforming the Dow? (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

09.03.26 - 15:45	Investing in The Cooper Companies (COO)? Don′t Miss Assessing Its International Revenue Trends (Zacks)
	Examine The Cooper Companies' (COO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock....

06.03.26 - 20:30	Is The Cooper Companies (COO) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
	The Cooper Companies (COO) is well positioned to outperform the market, as it exhibits above-average growth in financials....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Dem Morgenrot und dem Frauenrat ist nicht zu trauen. - Sprichwort Frankreich

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram